-
Tytuł:
-
Antibiotic dry buffalo therapy: effect of intramammary administration of benzathine cloxacillin against Staphylococcus aureus mastitis in dairy water buffalo.
-
Autorzy:
-
Guccione J; Department of Veterinary Medicine and Animal Production, University of Napoli Federico II, Via Delpino 1, 80137, Naples, Italy.
D'Andrea L; Department of Veterinary Medicine and Animal Production, University of Napoli Federico II, Via Delpino 1, 80137, Naples, Italy. .
Pesce A; Istituto Zooprofilattico del Mezzogiorno, Via A. Jervolino 19, Caserta District, 81100, Tuoro, Italy.
Toni F; Zoetis, Italia s.r.l., Via Andrea Doria 41M, 00192, Rome, Italy.
Borriello G; Department of Veterinary Medicine and Animal Production, University of Napoli Federico II, Via Delpino 1, 80137, Naples, Italy.
Salzano C; Istituto Zooprofilattico del Mezzogiorno, Via A. Jervolino 19, Caserta District, 81100, Tuoro, Italy.
Diuccio F; Zoetis, Italia s.r.l., Via Andrea Doria 41M, 00192, Rome, Italy.
Pascale M; Veterinary practitioner, Caserta, Italy.
Ciaramella P; Department of Veterinary Medicine and Animal Production, University of Napoli Federico II, Via Delpino 1, 80137, Naples, Italy.
-
Źródło:
-
BMC veterinary research [BMC Vet Res] 2020 Jun 12; Vol. 16 (1), pp. 191. Date of Electronic Publication: 2020 Jun 12.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: London : BioMed Central, 2005-
-
MeSH Terms:
-
Buffaloes*
Anti-Bacterial Agents/*therapeutic use
Cloxacillin/*analogs & derivatives
Mastitis/*veterinary
Staphylococcal Infections/*veterinary
Animals ; Anti-Bacterial Agents/administration & dosage ; Cattle ; Cloxacillin/administration & dosage ; Cloxacillin/therapeutic use ; Dairying ; Female ; Italy ; Lactation ; Mastitis/drug therapy ; Milk/statistics & numerical data ; Staphylococcal Infections/drug therapy ; Staphylococcus aureus/drug effects
-
References:
-
J Dairy Sci. 1994 Jan;77(1):75-9. (PMID: 8120207)
J Dairy Sci. 2002 Dec;85(12):3250-9. (PMID: 12512598)
Vet Rec. 2018 Jun 2;182(22):637. (PMID: 29858319)
Vet Rec. 2019 Jan 5;184(1):29-30. (PMID: 30606859)
Sci Rep. 2019 Nov 1;9(1):15850. (PMID: 31676851)
N Z Vet J. 2018 Jan;66(1):44-47. (PMID: 28988520)
BMC Vet Res. 2016 Jun 14;12(1):107. (PMID: 27297174)
Cattle Pract. 2008;16:200-208. (PMID: 20396602)
Vet Rec. 2016 Jan 23;178(4):93-4. (PMID: 26795861)
J Dairy Sci. 2014;97(4):2219-25. (PMID: 24565324)
Res Vet Sci. 2020 Feb;128:129-134. (PMID: 31783263)
J Dairy Sci. 1990 Mar;73(3):639-47. (PMID: 2341639)
J Dairy Sci. 2014 Dec;97(12):7606-13. (PMID: 25459906)
J Dairy Sci. 2016 Oct;99(10):8259-8266. (PMID: 27448856)
PLoS One. 2017 Oct 27;12(10):e0187252. (PMID: 29077759)
J Dairy Res. 2017 Nov;84(4):391-394. (PMID: 29154738)
J Dairy Sci. 2018 Jul;101(7):6336-6345. (PMID: 29605325)
J Dairy Sci. 2016 Apr;99(4):2945-2949. (PMID: 26805969)
J Dairy Res. 2019 Feb;86(1):40-42. (PMID: 30729911)
BMC Vet Res. 2017 Jan 19;13(1):29. (PMID: 28103866)
Vet J. 2011 Jun;188(3):313-7. (PMID: 20591704)
J Dairy Sci. 2008 Sep;91(9):3459-66. (PMID: 18765604)
J Dairy Sci. 2006 Mar;89(3):998-1003. (PMID: 16507694)
Vet Res. 2018 Jun 5;49(1):47. (PMID: 29866164)
J Am Vet Med Assoc. 1996 May 15;208(10):1705-8. (PMID: 8641956)
-
Contributed Indexing:
-
Keywords: Antibiotic dry therapy; Benzathine cloxacillin; Mastitis; Staphylococcus aureus; Water buffalo
-
Substance Nomenclature:
-
0 (Anti-Bacterial Agents)
AC79L7PV2G (benzathine cloxacillin)
O6X5QGC2VB (Cloxacillin)
-
Entry Date(s):
-
Date Created: 20200614 Date Completed: 20210113 Latest Revision: 20210113
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7291747
-
DOI:
-
10.1186/s12917-020-02410-7
-
PMID:
-
32532337
-
Background: Mastitis is one of the most costly diseases in Mediterranean buffalo (MB). At present, just a few specific antibiotics registered for this dairy specie have been synthetized. Efficacy of an antibiotic dry buffalo therapy (aDBT) against Staphylococcus aureus (S. aureus) mastitis, based on intra-quarter administration of 600 mg of benzathine cloxacillin, have been evaluated for the first time. Eighty MB's quarters received a drying-off therapy (aDBT-group) and 80 were left untreated (no-aDBT-group). They were sampled at drying-off (pre-treatment) and at the resumption of milking [< 10 days in milk (DIM)]. Fresh calver mastitis rate, dry period new mastitis rate, dry period cure rate, and persistent mastitis rate were calculated for clinical monitoring. Overall proportion of positive quarters/animals, quarters affected by mastitis or intramammary infections (IMI), effects on somatic cell count (SCC) and milk yield were also assessed.
Results: An inter-group difference (aDBT vs. no-aDBT) was recorded for all the indexes considered. An intra-group (drying-off vs. < 10 DIM) difference was detected in aDBT-group regarding the proportion of positive-cultured quarters and animals. Concerning the latter, an inter-groups difference was also recorded at second sampling. No clinical mastitis due to the S. aureus was observed. Regarding the subclinical ones, a higher intra-group difference was observed in aDBT than no-aDBT group, while an inter-group difference was recorded at second sampling. No protective effect was observed against IMI. SCC showed an inter-group difference at second sampling, while none difference was instead detected for milk yield.
Conclusions: The effects against S. aureus mastitis of benzathine cloxacillin administration at drying-off were assessed for the first time in MB. Its use shows encouraging results in reducing the proportion of mastitis and positive animals at the resumption of the lactation.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
